Researchers Behind Alzheimer’s Vaccine Recruited the First Human Patient
The Swedish biopharma company Alzinova AB developed a vaccine that can treat patients diagnosed with Alzheimer’s disease. The vaccine has been studied on animals, and it will now enter Phase 1b clinical study. The vaccine is named ALZ-101, and the…